HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of natsudaidain isolated from Citrus plants on TNF-alpha and cyclooxygenase-2 expression in RBL-2H3 cells.

AbstractOBJECTIVES:
Flavonoids inhibit the activity of chemical mediators released from mast cells. Our aim was to investigate the effects of natsudaidain, a polymethoxyflavone isolated from Citrus plants, on mast cells.
METHODS:
We investigated the inhibitory effects of natsudaidain, which is a polymethoxyflavone isolated from Citrus plants, on histamine release, tumour necrosis factor-alpha production and cyclooxygenase-2 expression in Ca ionophore-stimulated rat basophilic leukemia cells (A23187-stimulated RBL-2H3 cells) by spectrofluorometric, ELISA and immunoblotting methods.
KEY FINDINGS:
The percent of histamine release from A23187-stimulated RBL-2H3 cells pretreated with natsudaidain at 5, 25 and 50 microM was not changed as compared with non-treated A23187-stimulated cells. At 100 and 200 microM, natsudaidain pretreatment resulted in slightly reduced histamine release (% histamine release, 89.8+/-3.5% and 71.5+/-5.6% at 100 and 200 microM). Thus, natsudaidain hardly affects histamine release from RBL-2H3 cells, except at high concentrations. On the other hand, natsudaidain dose-dependently inhibited tumour necrosis factor-alpha protein and mRNA levels in A23187-stimulated RBL-2H3 cells; a concentration of 6.8 microM was required for a 50% reduction. In addition, all concentrations of this compound that we tested also inhibited cyclooxygenase-2 protein expression. The mRNA levels of cyclooxygenase-2 in A23187-stimulated RBL-2H3 cells treated with natsudaidain were also markedly decreased. The phosphorylated-p38 MAPK protein levels in A23187-stimulated RBL-2H3 cells treated with natsudaidain were lower than in the non-treated cells.
CONCLUSIONS:
These findings suggest that natsudaidain inhibits tumour necrosis factor-alpha and cyclooxygenase-2 production by suppressing p38 MAPK phosphorylation but not p65 NFkappaB phosphorylation, and that natsudaidain might alleviate inflammatory diseases.
AuthorsTakuya Matsui, Chihiro Ito, Masataka Itoigawa, Tadashi Okada, Hiroshi Furukawa
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 61 Issue 1 Pg. 109-14 (Jan 2009) ISSN: 0022-3573 [Print] England
PMID19126304 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Flavones
  • Flavonoids
  • Ionophores
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • natsudaidain
  • Calcimycin
  • nobiletin
  • Cyclooxygenase 2
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Analysis of Variance
  • Animals
  • Calcimycin (pharmacology)
  • Cell Line, Tumor
  • Chromatography, High Pressure Liquid
  • Citrus (chemistry)
  • Cyclooxygenase 2 (genetics, metabolism)
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Flavones (chemistry, isolation & purification, pharmacology)
  • Flavonoids (chemistry, isolation & purification, pharmacology)
  • Histamine Release (drug effects)
  • Immunoblotting
  • Ionophores (pharmacology)
  • Molecular Structure
  • Phosphorylation (drug effects)
  • Plant Leaves (chemistry)
  • RNA, Messenger (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Tumor Necrosis Factor-alpha (genetics, metabolism)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors, drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: